Por: RTTNews Health February 02, 2023
The U.S. Food and Drug Administration approved GlaxoSmithKline LLC's Jesduvroq tablets (daprodustat) for anemia caused by chronic kidney disease or CKD for adults who have been receiving dialysis for at least four months.It is the first oral treatment for anemia, i.e., decreased number of red blood cells, in the given indication that has received . Other FDA-approved treatments for this condition are injected into the blood or under the... + full article
RTTNews USA Health May 02, 2023
The U.S. Food and Drug Administration conditionally approved Elanco US Inc.'s Varenzin-CA1 (molidustat oral suspension) for treating anemia in cats with chronic kidney disease or CKD.It is the first drug for the control of nonregenerative anemia associated with CKD in cats.... + más
FDA Approves GSK's Drug For Anemia Caused By CKD For Adults On Dialysis | RTTNews
Race-Based Medicine Contributes To Civil Rights Violations, According To New Analysis | Forbes
Time USA Health March 03, 2023
GSK Plc’s vaccine for won the support of a key panel of U.S. regulatory advisers for use in people aged 60 and older, as the drugmaker races against Pfizer Inc. to bring to market the first vaccine for RSV. The panel of 12 outside advisers to the Food and Drug Administration... + más
FDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risks | CNBC
GSK vaccine for older adults granted FDA priority review | Fox Business
CNBC USA Health March 01, 2023
watch nowVIDEO1:5501:55FDA advisory panel votes in favor of adult RSV vaccine from GSK PLCThe Food and Drug Administration's independent panel of advisors on Wednesday recommended RSV vaccine for adults ages 60 and older, though they flagged potential safety issues over... + más
FDA Panel Backs GSK’s RSV Vaccine for Older People | Time
CNBC USA Health February 06, 2023
A COVID-19 patient using a ventilator rests while his blood goes through a kidney dialysis machine (L) on the Intensive Care Unit (ICU) floor at the Veterans Affairs Medical Center on April 21, 2020 in the Brooklyn borough of New York City.Robert Nickelsberg Getty ImagesHispanic... + más
As Prop. 29 vote looms, dialysis patients brace for change | Los Angeles Times
Your guide to Prop. 29 on California kidney dialysis centers | Los Angeles Times
Los Angeles Times USA Politics November 09, 2022
For a third time, California voters rejected a statewide mandate to increase medical staffing at dialysis centers. Proposition 29 would have required dialysis clinics to have a doctor, nurse practitioner or physician assistant present while patients are receiving care at any of... + más
Fox Business USA Business November 02, 2022
Check out what's clicking on FoxBusiness.com GSK opened 2% higher in U.S. trading Wednesday but closed down 2%. Shares rose after the drugmaker reported financial results that beat Wall Street forecasts and announced the Food and Drug Administration had accepted a biologics... + más
GSK Raises 2022 Guidance as 3Q Sales Beat Expectations -- Update | MarketWatch
Los Angeles Times USA Politics October 28, 2022
Socorro Reyes could feel himself getting sleepy as his blood pressure dropped. He was at his usual Friday morning treatment at a DaVita dialysis center. Reyes had settled into his chair to tune into a religious station to listen to Mass. Before his appointment ended, the... + más
Californians get third chance to alter dialysis clinic rules | Associated Press
Endorsement: On the ballot for a third time, Prop. 29 is a tired retread that could hurt dialysis patients | Los Angeles Times
About iurex | Privacy Policy | Disclaimer |